Hematologic Disease in Pregnancy

de Swiet's Medical Disorders in Obstetric Practice: Fifth Edition

Volumn , Issue , 2010, Pages 48-81

  McLintock, Claire ^a   Repke, John T ^b   Bucklin, Brenda ^c  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

^b PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Factor XI (FXI) deficiency, rare bleeding disorder autosomal recessive pattern of inheritance; Globin chain disordered synthesis of point mutations of globin gene; Hematologic disease in pregnancy; Hematologic features of B12 and folate deficiency; Hemoglobinopathies and thalassemias; Immune mediated thrombocytopenia autoimmune disorder, antibodies produced by B lymphocytes; Iron status assessment and identification of women at risk iron deficiency in pregnancy; Physiologic anemia well recognized during pregnancy; Screening tests for hemostatic defect detection; Thalassemias and hemoglobinopathies' diagnosis

Indexed keywords

EID: 79953033675     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444323016.ch2     Document Type: Chapter

References (102)

1. Scholl TO. Iron status during pregnancy: setting the stage for mother and infant. Am J Clin Nutr 2005;81:1218S-22S.
2. Beard JL. Effectiveness and strategies of iron supplementation during pregnancy. Am J Clin Nutr 2000;71:1288S-94S.
3. Allen LH. Anemia and iron deficiency: effects on pregnancy outcome. Am J Clin Nutr 2000;71:1280S-4S.
4. Scholl TO, Reilly T. Anemia, iron and pregnancy outcome. J Nutr 2000;130:443S-7S.
5. Pena-Rosas JP, Viteri FE. Effects of routine oral iron supplementation with or without folic acid for women during pregnancy. Cochrane Database of Systematic Reviews, 2006;3:CD004736.
6. Steer PJ. Maternal hemoglobin concentration and birth weight. Am J Clin Nutr 2000;71:1285S-7S.
7. Hoffman R, Benz EJ, Shattil SJ, Furie B, Cohen HJ, Silberstein LE. Hematology: basic principles and practice. Churchill Livingstone, Edinburgh, 1995.
8. Hokin BD, Butler T. Cyanocobalamin (vitamin B-12) status in seventh-day adventist ministers in Australia. Am J Clin Nutr 1999;70:576S-8S.
9. Koebnick C, Hoffmann I, Dagnelie PC, Heins UA, Wickramasinghe SN, Ratnayaka ID, et al. Long-term ovo-lacto vegetarian diet impairs vitamin B-12 status in pregnant women. J Nutr 2004; 134(12):3319-26.
10. Kuhne T, Bubl R, Baumgartner R. Maternal vegan diet causing a serious infantile neurological disroder due to vitamin B12 deficiency. Eur J Pediatr 1991;150:205-8.
11. Wardinsky TD, Montes RG, Friederich RL, Broadhurst RB, Sinnhuber V, Bartholomew D. Vitamin B12 deficiency associated with low breast-milk vitamin B12 concentration in an infant following maternal gastric bypass surgery. Arch Pediatr Adol Med 1995;149:1281-4.
12. Pitkin RM. Folate and neural tube defects. Am J Clin Nutr 2007;85:285S-8S.
13. Galloway MJ, Rushworth L. Red cell or serum folate? Results from the National Pathology Alliance benchmarking review. J Clin Pathol 2003;56:924-6.
14. Zittoun J, Zittoun R. Modern clinical testing strategies in cobalamin and folate deficiency. Semin Hematol 1999;36:35-46.
15. Vichinsky EP. Changing patterns of thalassemia worldwide. Ann NY Acad Sci 2005;1054:18-24.
16. Weatherall DJ, Clegg JB. The thalassemia syndromes, 4th edn. Blackwell Science, Oxford, 2001.
17. Angastiniotis M, Modell B. Global epidemiology of hemoglobin disorders. Ann NY Acad Sci 1998;850:251-69.
18. Lucke T, Pfister S, Durken M. Neurodevelopmental outcome and haematological course of a long-time survivor with homozygous alpha-thalassaemia: case report and review of the literature. Acta Paediatr 2005;94:1330-3.
19. Frenette PS, Atweh GF. Sickle cell disease: old discoveries, new concepts, and future promises. J Clin Invest 2007;117:850-8.
20. Madigan C, Malik P. Pathophysiology and therapy for haemoglobinopathies. Part I: sickle cell disease. Exp Rev Mol Med 2006;8:1-23.
21. Davies SC, Gilmore A. The role of hydroxyurea in the management of sickle cell disease. Blood Rev 2003;17:99-109.
22. Rees D, Olujohungbe AD, Parker NE, Stephens AD, Telfer P, Wright J. Guidelines for the management of the acute painful crisis in sickle cell disease. Br J Haematol 2003;120:744-52.
23. Leung TN, Lau TK, Chung TK. Thalassaemia screening in pregnancy. Curr Opin Obstet Gynecol 2005;17:129-34.
24. Tuck SM. Fertility and pregnancy in thalassemia major. Ann NY Acad Sci 2005;1054:300-7.
25. Serjeant GR, Loy LL, Crowther M, Hambleton IR, Thame M. Outcome of pregnancy in homozygous sickle cell disease. Obstet Gynecol 2004;103:1278-85.
26. Koshy M. Sickle cell disease and pregnancy. Blood Rev 1995;9:157-64.
27. Koshy M, Burd L, Wallace D, Moawad A, Baron J. Prophylactic red-cell transfusions in pregnant patients with sickle cell disease: a randomized cooperative study. N Engl J Med 1988;319:1447-52.
28. Lorey F, Charoenkwan P, Witkowska HE, Lafferty J, Patterson M, Eng B, et al. Hb H hydrops foetalis syndrome: a case report and review of literature. Br J Haematol 2001;115:72-8.
29. Lorey F, Cunningham G, Vichinsky EP, Lubin BH, Witkowska HE, Matsunaga A, et al. Universal newborn screening for Hb H disease in California. Genet Test 2001;5:93-100.
30. Li D, Liao C, Li J, Xie X, Huang Y, Zhong H. Detection of alpha-thalassemia in beta-thalassemia carriers and prevention of Hb Bart's hydrops fetalis through prenatal screening. Haematologica 2006;91:649-51.
31. Chan V, Ng EHY, Yam I, Yeung WSB, Ho PC, Chan TK. Experience in preimplantation genetic diagnosis for exclusion of homozygous 0 thalassemia. Prenat Diagn 2006;26:1029-36.
32. Qureshi N, Foote D, Walters MC, Singer ST, Quirolo K, Vichinsky EP. Outcomes of preimplantation genetic diagnosis therapy in treatment of beta-thalassemia: a retrospective analysis. Ann NY Acad Sci 2005;1054:500-3.
33. Kuliev A, Rechitsky S, Verlinsky O, Ivakhnenko V, Evsikov S, Wolf G, et al. Preimplantation diagnosis of thalassemias. J Assist Reprod Genet 1998;15:219-25.
34. Phupong V. An increase of the cardiothoracic ratio leads to a diagnosis of Bart's hydrops. J Med Assoc Thai 2006;89:509-12.
35. Kaplan C, Daffos F, Forestier F, Tertian G, Catherine N, Pons JC, et al. Fetal platelet counts in thrombocytopenic pregnancy. Lancet 1990;336:979-82.
36. Burrows RF, Kelton JG. Incidentally detected thrombocytopenia in healthy mothers and their infants. N Engl J Med 1988;319(3):142-5.
37. Burrows RF, Kelton JG. Pregnancy in patients with idiopathic thrombocytopenic purpura: assessing the risks for the infant at delivery. Obstet Gynecol Surv 1993;48:781-8.
38. Sainio S, Kekomaki R, Riikonen S, Teramo K. Maternal thrombocytopenia at term: a population-based study. Acta Obstet Gynecol Scand 2000;79:744-9.
39. Burrows RF, Kelton JG. Fetal thrombocytopenia and its relation to maternal thrombocytopenia. N Engl J Med 1993;329:1463-6.
40. George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996;88:3-40.
41. Brighton TA, Evans S, Castaldi PA, Chesterman CN, Chong BH. Prospective evaluation of the clinical usefulness of an antigen-specific assay (MAIPA) in idiopathic thrombocytopenic purpura and other immune thrombocytopenias. Blood 1996;88:194-201.
42. Cines DB, Dusak B, Tomaski A, Mennuti M, Schreiber AD. Immune thrombocytopenic purpura and pregnancy. N Engl J Med 1982;306:826-31.
43. Al-Mofada SM, Osman ME, Kides E, Al-Momen AK, Al- Herbish AS, Al-Mobaireek K. Risk of thrombocytopenia in the infants of mothers with idiopathic thrombocytopenia. Am J Perinat 1994;11:423-6.
44. Burrows RF, Kelton JG. Low fetal risks in pregnancies associated with idiopathic thrombocytopenic purpura. Am J Obstet Gynecol 1990;163:1147-50.
45. Moutet A, Fromont P, Farcet JP, Rotten D, Bettaieb A, Duedari N, et al. Pregnancy in women with immune thrombocytopenic purpura. Arch Intern Med 1990;150:2141-5.
46. Payne SD, Resnik R, Moore TR, Hedriana HL, Kelly TF. Maternal characteristics and risk of severe neonatal thrombocytopenia and intracranial hemorrhage in pregnanciescomplicated by autoimmune thrombocytopenia. Am J Obstet Gynecol 1997;177:149-55.
47. Samuels P, Bussel JB, Braitman LE, Tomaski A, Druzin ML, Mennuti MT, et al. Estimation of the risk of thrombocytopenia in the offspring of pregnant women with presumed immune thrombocytopenic purpura. N Engl J Med 1990;323:229-35.
48. Sharon R, Tatarsky I. Low fetal morbidity in pregnancy associated with acute and chronic idiopathic thrombocytopenic purpura. Am J Hematol 1994;46:87-90.
49. Valat AS, Caulier MT, Devos P, Rugeri L, Wibaut B, Vaast P, et al. Relationships between severe neonatal thrombocytopenia and maternal characteristics in pregnancies associated with autoimmune thrombocytopenia. Br J Haematol 1998;103:397-401.
50. Webert KE, Mittal R, Sigouin C, Heddle NM, Kelton JG. A retrospective 11-year analysis of obstetric patients with idiopathic thrombocytopenic purpura. Blood 2003;102:4306-11.
51. Yamada H, Kato EH, Kishida T, Negishi H, Makinoda S, Fujimoto S. Risk factors for neonatal thrombocytopenia in pregnancy complicated by idiopathic thrombocytopenic purpura. Ann Hematol 1998;76:211-14.
52. British Committee for Standards in Haematology General Haematology Task Force. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol 2003;120:574-96.
53. Christiaens GC, Nieuwenhuis HK, Bussel JB. Comparison of platelet counts in first and second newborns of mothers with immune thrombocytopenic purpura. Obstet Gynecol 1997;90:546-52.
54. Arnold DM, Dentali F, Crowther MA, Meyer RM, Cook RJ, Sigouin C, et al. Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura. Ann Intern Med 2007;146:25-33.
55. McNeill MJ, Thorburn J. Cannulation of the epidural space. A comparison of 18- and 16-gauge needles. Anaesthesia 1988; 43:154-5.
56. Verniquet AJ. Vessel puncture with epidural catheters. Experience in obstetric patients. Anaesthesia 1980;35:660-2.
57. Lee LA, Posner KL, Domino KB, Caplan RA, Cheney FW. Injuries associated with regional anesthesia in the 1980s and 1990s: a closed claims analysis. Anesthesiology 2004;101:143-52.
58. Moen V, Dahlgren N, Irestedt L. Severe neurological complications after central neuraxial blockades in Sweden 1990-1999. Anesthesiology 2004;101:950-9.
59. American Society of Anesthesiologists Task Force on Obstetric Anesthesia. Practice guidelines for obstetric anesthesia: an updated report by the American Society of Anesthesiologists Task Force on Obstetric Anesthesia. Anesthesiology 2007;106:843-63.
60. Ramanathan J, Sibai BM, Vu T, Chauhan D. Correlation between bleeding times and platelet counts in women with preeclampsia undergoing cesarean section. Anesthesiology 1989;71:188-91.
61. Rodgers RP, Levin J. A critical reappraisal of the bleeding time. Semin Thromb Hemostas 1990;16:1-20.
62. Prieto JA, Mastrobattista JM, Blanco JD. Coagulation studies in patients with marked thrombocytopenia due to severe preeclampsia. Am J Perinatol 1995;12:220-2.
63. McCrae KR, Samuels P, Schreiber AD. Pregnancy-associated thrombocytopenia: pathogenesis and management. Blood 1992;80:2697-714.
64. Rolbin SH, Abbott D, Musclow E, Papsin F, Lie LM, Freedman J. Epidural anesthesia in pregnant patients with low platelet counts. Obstet Gynecol 1988;71:918-20.
65. Rasmus KT, Rottman RL, Kotelko DM, Wright WC, Stone JJ, Rosenblatt RM. Unrecognized thrombocytopenia and regional anesthesia in parturients: a retrospective review. Obstet Gynecol 1989;73:943-6.
66. Beilin Y, Zahn J, Comerford M. Safe epidural analgesia in thirty parturients with platelet counts between 69,000 and 98,000 mm(-3). Anesth Analg 1997;85:385-8.
67. Urato AC, Repke JT. May-Hegglin anomaly: a case of vaginal delivery when both mother and fetus are affected. Am J Obstet Gynecol 1998;179:260-1.
68. Lopez JA, Andrews RK, Afshar-Kharghan V, Berndt MC. Bernard - Soulier syndrome. Blood 1998;91:4397-418.
69. Khalil A, Seoud M, Tannous R, Usta I, Shamseddine A. Bernard - Soulier syndrome in pregnancy: case report and review of the literature. Clin Lab Haematol 1998;20:125-8.
70. Peng TC, Kickler TS, Bell WR, Haller E. Obstetric complications in a patient with Bernard-Soulier syndrome. Am J Obstet Gynecol 1991;165:425-6.
71. George JN, Caen JP, Nurden AT. Glanzmann's thrombasthenia: the spectrum of clinical disease. Blood 1990;75:1383-95.
72. Bellucci S, Caen J. Molecular basis of Glanzmann's thrombasthenia and current strategies in treatment. Blood Rev 2002;16:193-202.
73. Kale A, Bayhan G, Yalinkaya A, Yayla M. The use of recombinant factor VIla in a primigravida with Glanzmann's thrombasthenia during delivery. J Perinat Med 2004;32:456-8.
74. Kouides PA, Phatak PD, Burkart P, Braggins C, Cox C, Bernstein Z, et al. Gynaecological and obstetrical morbidity in women with type I von Willebrand disease: results of a patient survey. Haemophilia 2000;6:643-8.
75. Sadler JE, Budde U, Eikenboom JCJ, Favaloro EJ, Hill FGH, Holmberg L, et al. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor. J Thromb Haemost 2006;4:2103-14.
76. Sanchez-Luceros A, Meschengieser SS, Marchese C, Votta R, Casais P, Woods AI, et al. Factor VIII and von Willebrand factor changes during normal pregnancy and puerperium. Blood Coag Fibrinol 2003;14:647-51.
77. Hepner DL, Tsen LC. Severe thrombocytopenia, type 2B von Willebrand disease and pregnancy. Anesthesiology 2004;101: 1465-7.
78. Kadir RA, Lee CA, Sabin CA, Pollard D, Economides DL. Pregnancy in women with von Willebrand's disease or factor XI deficiency. Br J Obstet Gynaecol 1998;105:314-21.
79. Mannucci PM. Treatment of von Willebrand's disease. J Intern Med 1997;740:129-32.
80. Sanchez-Luceros A, Meschengieser SS, Turdo K, Arizo A, Woods AI, Casais P, et al. Evaluation of the clinical safety of desmopressin during pregnancy in women with a low plasmatic von Willebrand factor level and bleeding history. Thromb Res 2007;120:387-90.
81. Jones BP, Bell EA, Maroof M. Epidural labor analgesia in a parturient with von Willebrand's disease type IIA and severe preeclampsia. Anesthesiology 1999;90:1219-20.
82. Milaskiewicz RM, Holdcroft A, Letsky E. Epidural anaesthesia and von Willebrand's disease. Anaesthesia 1990;45:462-4.
83. Stedeford JC, Pittman JA. Von Willebrand's disease and neuroaxial anaesthesia. Anaesthesia 2000;55:1228-9.
84. Ruppen W, Derry S, McQuay H, Moore RA. Incidence of epidural hematoma, infection, and neurological injury in obstetric pateints with epidural analgesia/anaesthesia. Anesthesiology 2006;105:394-9.
85. Campbell DC. Parenteral opioids for labor analgesia. Clin Obstet Gynecol 2003;46:616-22.
86. Rodeghiero F, Castaman G. Treatment of von Willebrand disease. Semin Hematol 2005;42:29-35.
87. Cohen S, Zada Y. Neuroaxial block for von Willebrand's disease. Anaesthesia 2001;56:397.
88. Roque H, Funai E, Lockwood CJ. von Willebrand disease and pregnancy. J Matern Fetal Med 2000;9:257-66.
89. Sharma SK LR. Hematologic and coagulation disorders. In: Chestnut DH (ed) Obstetric anesthesia: principles and practice, 3rd edn. Elsevier Mosby, Philadelphia, 2004.
90. Andrew M, Paes B, Milner R, Johnston M, Mitchell L, Tollefsen DM, et al. Development of the human coagulation system in the full-term infant. Blood 1987;70:165-72.
91. Lavery S. Preimplantation genetic diagnosis: new reproductive options for carriers of haemophilia. Haemophilia 2004;10:126-32.
92. Ray JG. DDAVP use during pregnancy: an analysis of its safety for mother and child. Obstet Gynecol Surv 1998;53:450-5.
93. Hack G, Hofmann P, Brackmann HH, Stoeckel H, Pichotka H. Regional anaesthesia in haemophiliacs. Anasth Intensivther Notfallmed 1980;15:45-51.
94. O'Connell NM. Factor XI deficiency. Semin Hematol 2004;41: 76-81.
95. Kadir RA. Women and inherited bleeding disorders: pregnancy and delivery. Semin Hematol 1999;36:28-35.
96. Myers B, Pavord S, Kean L, Hill M, Dolan G. Pregnancy outcome in Factor XI deficiency: incidence of miscarriage, antenatal and postnatal haemorrhage in 33 women with Factor XI deficiency. Br J Obstet Gynecol 2007;114:643-6.
97. Singh AJ, Harnet MJ, Connors MJ, Camman WR. Factor XI deficiency and obstetrical anesthesia. Anesth Analg 2009;108:1882-5.
98. Kadir RA, Kingman CEC, Chi C, O'Connell NM, Riddell A, Lee CA, et al. Screening for factor XI deficiency amongst pregnant women of Ashkenazi Jewish origin. Haemophilia 2006;12:625-8.
99. Kulkarni AA, Lee CA, Kadir RA. Pregnancy in women with congenital factor VII deficiency. Haemophilia 2006;12: 413-16.
100. Mariani G, Dolce A, Marchetti G, Bernardi F. Clinical picture and management of congenital factor VII deficiency. Haemophilia 2004;10:180-3.
101. Ichinose A, Asahina T, Kobayashi T. Congenital blood coagulation factor XIII deficiency and perinatal management. Curr Drug Targ 2005;6:541-9.
102. Asahina T, Kobayashi T, Takeuchi K, Kanayama N. Congenital blood coagulation factor XIII deficiency and successful deliveries: a review of the literature. Obstet Gynecol Surv 2007;62:255-60.